SILVER SPRING, Md., Oct. 31, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of October 31, 2011.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.
Events and Speeches for the Commissioner and FDA leadership:
Monday, 11/7 – FDA Commissioner Margaret A. Hamburg, M.D., is part of the plenary session "Priming the Pump: Filling the Therapeutic Pipeline," at the Partnering for Cures Conference. 8 a.m., Grand Hyatt New York, 109 East 42nd Street, New York City.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
Thursday, 11/10 – FDA Commissioner Hamburg delivers the plenary luncheon speech at the 2011 Conference on Clinical Cancer Research co-sponsored by the Engelberg Center for Health Care Reform at the Brookings Institution. 12 p.m., The Grand Hyatt, 1000 H Street N.W., Washington.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
Meetings, Workshops and Congressional Testimony:
Wednesday, 11/2 – The Endocrinologic and Metabolic Drugs Advisory Committee discusses supplemental new drug applications for Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe) tablets. 8 a.m., Hilton Washington DC North/Silver Spring, 8727 Colesville Road, The Ballrooms, Silver Spring, Md.
Press Office Contact: Morgan Liscinsky, 301-796-0397, [email protected]
Friday, 11/4 – The National Mammography Quality Assurance Advisory Committee provides advice and recommendations on proposed changes to the Mammography Quality Standard Act policies and inspection procedures, accreditation body review of soft copy mammography images, reporting breast density on mammography reports, and patient summaries. 8 a.m., Holiday Inn Gaithersburg, 2 Montgomery Village Avenue, Ballroom, Gaithersburg, Md.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
On the Web:
FDA Video: Health Fraud Scams – Be Smart, Be Aware, Be Careful
The FDA Web page on Drug Shortages
Press Office Contact: Shelly Burgess, 301-796-4651, [email protected]
FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, [email protected]
List of FDA press officers and beats
More Resources:
SOURCE U.S. Food and Drug Administration
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article